CME/CE
Episodes 17-32 of 51
P. Gabriel Steg, MD
Lale Tokgözoğlu, MD
Fabrice Martens, MD, PhD, FESC
Prof. Kausik Ray, MBChB, MD, MPhil
Lale Tokgözoğlu, MD
Fabrice Martens, MD, PhD, FESC
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
- MinuteCE®
Novel oral pathways in LDL-C lowering therapy: The new promise of CETPi
1.00 program creditErin D. Michos, MD, MHS, FACC, FAHA, FASE
- MinuteCE®
The evolving need and challenges to reach LDL-c targets in high-risk patients
1.00 program creditProf. Kausik Ray, MBChB, MD, MPhil
Roxana Mehran, MD
Stephen Nicholls, FRACP, FACC, FESC, FAHA
Stephen Nicholls, FRACP, FACC, FESC, FAHA
John Kastelein, MD, PhD
Roxana Mehran, MD
- MinuteCE®
New insights on CETP inhibition from genetic research and clinical trials
1.00 program creditJohn Kastelein, MD, PhD
Antonis Pantazis, MD
Pablo García-Pavia, MD, PhD
Antonis Pantazis, MD
Pablo García-Pavia, MD, PhD
Carolyn Ho, MD
Carolyn Ho, MD
- MinuteCE®
New paradigms in the prevention of ASCVD: The role of EPA and triglycerides
1.00 credit 3 episodesRichard Hobbs, MD
Lale Tokgözoğlu, MD
Victor Aboyans, MD, PhD
- MinuteCE®
Integrating icosapent ethyl in preventive strategies: Practical guidance
1.00 program creditVictor Aboyans, MD, PhD